Investment News and Research RSS Feed - Investment News and Research

New prototype allows patients with severe functional disability to be more active and independent

New prototype allows patients with severe functional disability to be more active and independent

The European R&D project BrainAble, led by Barcelona Digital, has just successfully ended by developing a prototype that allows patients with severe functional disability to be more active and independent. [More]
Wheat Initiative: 60% increase in wheat production needed by 2050

Wheat Initiative: 60% increase in wheat production needed by 2050

By 2050, a 60% increase in wheat production will be needed to meet the demand of a growing population. The Wheat Initiative, an international consortium gathering public institutions and private companies, was created as part of the 2011 action plan of the G20 Agricultural Ministries to coordinate global wheat research and participate to global food security. [More]
Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

In medical school, we were taught not to withhold information from our patients or to be "paternal" in making decisions for them. We internalized the idea that fully informed patients are better equipped to make treatment decisions. [More]
PCF funds two new Young Investigators in China to lead research projects on prostate cancer

PCF funds two new Young Investigators in China to lead research projects on prostate cancer

The Prostate Cancer Foundation today announced that it is funding two more Young Investigators in China to lead innovative research projects within the country and expand PCF's global knowledge exchange on game-changing research in prostate cancer. [More]

Prestige Brands Holdings reports record revenues of $154.5 million in fourth quarter 2013

Prestige Brands Holdings, Inc. today announced record results for the fourth quarter and the fiscal year ended March 31, 2013, driven by strong growth in both the legacy and acquired core brands in the Company's Over-the-Counter Healthcare segment. [More]
RuiYi signs agreement with Genor BioPharma for development of RYI-008 in China

RuiYi signs agreement with Genor BioPharma for development of RYI-008 in China

RuiYi Inc. announced today that it has entered into an exclusive license and collaborative development agreement with Genor BioPharma for the development of RYI-008 in China. [More]

Community Catalyst study shows dental therapists expand access to people in remote areas

Lack of access to dental care in the United States has reached epic proportions. Dental disease is the number one chronic illness affecting children - more common than asthma. The Institute of Medicine clearly states that the current dental delivery system doesn't work for a third of the people in the U.S. [More]
Leptospirosis: The newest public health threat in Africa

Leptospirosis: The newest public health threat in Africa

The newest public health threat in Africa, scientists have found, is coming from a previously unknown source: the banded mongoose. [More]
Article spotlights new way to find adverse drug reactions within electronic health records

Article spotlights new way to find adverse drug reactions within electronic health records

The time may be fast approaching for researchers to take better advantage of the vast amount of valuable patient information available from U.S. electronic health records. Lian Duan, an NJIT computer scientist with an expertise in data mining, has done just that with the recent publication of "Adverse Drug Effect Detection," IEEE Journal of Biomedical and Health Informatics (March, 2013). [More]

AGA Research Foundation receives grant for gastroenterology research

Today, the American Gastroenterological Association announced that Takeda Pharmaceuticals U.S.A., Inc. will provide a $1.5 million unrestricted grant to the AGA Research Foundation endowment. [More]
New British technologies are transforming healthcare and saving lives

New British technologies are transforming healthcare and saving lives

Innovative projects including: smart-phone test and tracking systems for infectious diseases; fibre optic probes that can monitor people's condition in intensive care; and in-home sensors that can relay patient information to doctors immediately, have benefitted from a -32 million investment. [More]
RWJF announces recipients of four new grants from Future of Nursing National Research Agenda

RWJF announces recipients of four new grants from Future of Nursing National Research Agenda

The Robert Wood Johnson Foundation today announced the recipients of four new grants from its Future of Nursing National Research Agenda. The new grants examine nurse residency programs and scope of practice regulations. [More]

Health experts examine how density of fast-food outlets associated with prevalence of obesity

Many studies have linked the meals served at fast-food outlets to obesity, but is there a relationship between the number of restaurants in a country and the girth of its population? [More]

World Lupus Day: Lupus organizations to rally together to raise awareness of lupus

The Lupus Foundation of America and lupus organizations around the globe are rallying together on May 10, World Lupus Day, to urge action and raise awareness of lupus, a mysterious and devastating disease that ravages different parts of the body. [More]
Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials. [More]

CCIM institute accepts UT Dallas as university partner

The CCIM Institute has accepted UT Dallas as a university partner, putting graduate students in real estate on the fast track to earning its prestigious expert designation. [More]
Protein tumor necrosis factor-alpha is a powerful weapon to control cancer

Protein tumor necrosis factor-alpha is a powerful weapon to control cancer

The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer therapy has been severely limited. [More]
Good Start Genetics gets $28M loan from Capital Royalty

Good Start Genetics gets $28M loan from Capital Royalty

Good Start Genetics, Inc., an innovative molecular diagnostics company that has developed the new gold standard in carrier screening, today announced that it has closed a non-dilutive loan facility for up to $28 million of capital from Capital Royalty L.P. [More]
New NTD Special Envoys to focus on eliminating NTD primarily on LAC region

New NTD Special Envoys to focus on eliminating NTD primarily on LAC region

Today, the Global Network for Neglected Tropical Diseases, a major initiative of the Sabin Vaccine Institute, announced His Excellency, President Alvaro Arz- Irigoyen of Guatemala (1996-2000), His Excellency, President Ricardo Lagos Escobar of Chile (2000-2006) and former Pan American Health Organization Director Dr. Mirta Roses Periago as the organization's newest Neglected Tropical Disease Special Envoys. [More]
Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria. [More]